Cargando…
AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide
Glioma is the most frequent primary malignancy in the brain; temozolomide (TMZ) is the first-line chemotherapeutic agent used to combat this tumor. We showed here that astrocyte elevated gene-1 (AEG-1) was overexpressed in glioma tissues and associated with a worse subtype and a poor prognosis. CCK-...
Autores principales: | Li, Jing, Sun, Yuchen, Sun, Xuanzi, Zhao, Xu, Ma, Yuan, Wang, Yuzhu, Zhang, Xiaozhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405821/ https://www.ncbi.nlm.nih.gov/pubmed/34462446 http://dx.doi.org/10.1038/s41598-021-96647-3 |
Ejemplares similares
-
Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma
por: Li, Jing, et al.
Publicado: (2022) -
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018) -
Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016) -
AEG-1 expression correlates with CD133 and PPP6c levels in human glioma tissues
por: Guo, Jia, et al.
Publicado: (2014) -
Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)